Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support
Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Jun 26, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding better ways to encourage people to get vaccinated, especially those who might be hesitant or refuse vaccines. The researchers want to create a system that helps both patients and healthcare providers make informed decisions about vaccinations. By using this system, they hope to see an increase in the number of people who choose to get vaccinated.
To be eligible for this trial, participants should have an upcoming appointment at the Children's Healthcare of Atlanta Hughes Spalding Primary Care Clinic within the next two days and must have a valid mobile phone number or email address on file. Initially, the trial will focus on individuals who are due for a COVID-19 vaccine, and later it will include those due for any vaccines recommended by health guidelines. If you participate, you can expect to receive helpful information about vaccines before your appointment, making it easier to make a decision about getting vaccinated. The trial is not yet recruiting participants, but it aims to improve vaccination rates and help protect the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient has an upcoming appointment in 2 business days at Children's Healthcare of Atlanta Hughes Spalding Primary Care Clinic.
- • A valid mobile phone number or e-mail address is available in the EHR as of 2 business days prior to the appointment date.
- Phase 1: COVID-19 Vaccine only:
- • Due for a COVID-19 vaccine based on Epic Systems© COVID-19 vaccine health maintenance topic.
- Phase 2: All Vaccines:
- • Due for any vaccines based on Epic Systems© implementation using health maintenance topics of the Centers for Disease Control CDS for Immunization (CDSi) specifications.
- Exclusion Criteria:
- • None
About Johns Hopkins Bloomberg School Of Public Health
The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Daniel Salmon, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported